Front Matter (PDF) - BJA
Front Matter (PDF) - BJA
Front Matter (PDF) - BJA
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
ANAESTHESIA"*<br />
HAS COME A<br />
LONG WAY... J<br />
...SO HAS<br />
REVERSAL<br />
In recent years, many advances have been made in the<br />
field of anaesthesia, including reversal of residual<br />
neuromuscular blockade.<br />
A. H. Robins has been a major contributor to this area<br />
with Robinul.<br />
As an anticholinergic agent Robinul provides significant<br />
advantages over atropine: less initial tachycardia',<br />
better protection against the peripheral muscarinic<br />
effects of neostigmine 1 , and a better quality of recovery 2 .<br />
At reversal, when administered simultaneously with<br />
neostigmine, Robinul is associated with greater<br />
cardiostability than separate injections 3 .<br />
ROBINUL- NEOSTIGMINE injection contains standard<br />
doses of Robinul and neostigmine in a 1ml ampoule,<br />
provides dependable and convenient reversal of<br />
residual neuromuscular blockade, and contributes<br />
further towards improvements in anaesthesia.<br />
I<br />
GLYCOPYRROLATE<br />
NEOSTIGMINE<br />
NKOSTK.MINK MKTHYLSl LPHATK<br />
Each lml contains Gtycopyrroltte USP 500 micrograms (OSmg) Neostigmine Methyfsulphate BP 2500 micrograms I2.5mg! Mication: Reversa<br />
3t residual non-d«potarittng(comp«1itive) neuromuscular block Oau$»m4AJmmittTWt\on: Intravenous injection Adults and Older Patients 1 2ml 12500 microgfams neostigmine methylsulphaWSOO<br />
rncrogrtfttf gtycopyrroiale to 5000 nucrograms neosugmme iMthylsulphate/1000 micrograms glycapyrrolaiel over a penod of 10-30 seconds Alternatively 0 02rnl/kg 150 microgram<br />
- * • • - - - rrogrems gtycopyrrolate per kg body weight) over a psnod of 10 30 seconds Children 002ml/kg (50 micrograms neostigmine methylsulphate/10 micro<br />
pam gfycopyrrobM ptr kg tMdy wwgfati owtr a period of 10-30 seconds These doses may be repealed if adequate reversal is not achieved Total doses m excess of 2ml are nc<br />
recouwModed. CMtot-MfeaiMr HytmteuithniY to ingredients. Mechanical obstruction of gastrointestinal or urinary tracts Concomitant administration of suKamethomum Sid* ffftcts<br />
Meostigmine induced (muscarinic) side effects - bradycardia, increased oropharyngeat secretions, cardiac dysrhythmias. bronchospasm. increased gasuointesuna< activiiy etc<br />
Glycopyrrolate induced side effects dry mouth, difficult-/ m micturition, cardiac dysrhythmias. disturbances of visual accommodation, inhibition of sweating Prtcjti—t: Use with caution n<br />
aatients with bronchospasm. severe bradycardia. fever, glaucoma, coronary artery disease, congestive heart failure, cardiac dysrhyitimias. hypertension, thyrotowcosis, epilepsy or Paritm<br />
wmsm Use with caution m patients wtth mtestmaf anastomoses. Safety m pregnancyJlactatton has not been established B**tc NHS price CIO 37110 * lml ampoules! Ufal Cm»§»Pf P0^<br />
Padtaft Q»aaMt*s Packs of 10 ampoules fwrtk$t WansatiMi Robtnol Neostigmine Infection can be used when atropine has been used as a pre-operatrve arm-cholmergic Prefac<br />
01OOVOO99 Pi—'m Alfcoriirtoii Wimfcii 86^77/1 fMtnaces 1 Mirakhur RK et al Anaesth Analg 19 81. 60. 557-562 2 Sheref SE Br J Anaesth 1985. 57 IBS 191 3 Mostafa SM<br />
itocevic M Anaesthesia 1984; 39 1207 1213 full Data Sheet available on request from A H.Robins Company Ltd.Sussex Manor Business Park. Gatwick Road, Crawley, West Sussex RH10 ?NH